BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7596957)

  • 1. Aniracetam reverses memory impairment in rats.
    Martin JR; Moreau JL; Jenck F
    Pharmacol Res; 1995 Feb; 31(2):133-6. PubMed ID: 7596957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodents.
    Cumin R; Bandle EF; Gamzu E; Haefely WE
    Psychopharmacology (Berl); 1982; 78(2):104-11. PubMed ID: 6817363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of BY-1949 on three kinds of experimental amnesia in rodents].
    Tanabe S; Ikeda Y; Sugawa M; Iwasaki T
    Yakubutsu Seishin Kodo; 1990 Jun; 10(2):297-305. PubMed ID: 2251878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 5-HT(6) receptor antagonist SB-271046 reverses scopolamine-disrupted consolidation of a passive avoidance task and ameliorates spatial task deficits in aged rats.
    Foley AG; Murphy KJ; Hirst WD; Gallagher HC; Hagan JJ; Upton N; Walsh FS; Regan CM
    Neuropsychopharmacology; 2004 Jan; 29(1):93-100. PubMed ID: 14571256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of D-cycloserine and aniracetam on spatial learning in rats with entorhinal cortex lesions.
    Zajaczkowski W; Danysz W
    Pharmacol Biochem Behav; 1997 Jan; 56(1):21-9. PubMed ID: 8981605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of aniracetam on one-trial passive avoidance tests and cholinergic neurons in discrete brain regions of rats.
    Toide K
    Arch Int Pharmacodyn Ther; 1989; 298():25-37. PubMed ID: 2757465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between oxiracetam, aniracetam and scopolamine on behavior and brain acetylcholine.
    Spignoli G; Pepeu G
    Pharmacol Biochem Behav; 1987 Jul; 27(3):491-5. PubMed ID: 3659072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamide (DM-9384) on learning and memory in rats.
    Sakurai T; Ojima H; Yamasaki T; Kojima H; Akashi A
    Jpn J Pharmacol; 1989 May; 50(1):47-53. PubMed ID: 2724699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dual-acting AChE inhibitor and H3 receptor antagonist UW-MD-72 reverses amnesia induced by scopolamine or dizocilpine in passive avoidance paradigm in rats.
    Sadek B; Khan N; Darras FH; Pockes S; Decker M
    Physiol Behav; 2016 Oct; 165():383-91. PubMed ID: 27568232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vinpocetine: nootropic effects on scopolamine-induced and hypoxia-induced retrieval deficits of a step-through passive avoidance response in rats.
    DeNoble VJ; Repetti SJ; Gelpke LW; Wood LM; Keim KL
    Pharmacol Biochem Behav; 1986 Apr; 24(4):1123-8. PubMed ID: 3714768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nefiracetam on amnesia animal models with neuronal dysfunctions.
    Hiramatsu M; Shiotani T; Kameyama T; Nabeshima T
    Behav Brain Res; 1997 Feb; 83(1-2):107-15. PubMed ID: 9062668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative studies on the effects of the nootropic drugs adafenoxate, meclofenoxate and piracetam, and of citicholine on scopolamine-impaired memory, exploratory behavior and physical capabilities (experiments on rats and mice).
    Petkov VD; Mosharrof AH; Petkov VV
    Acta Physiol Pharmacol Bulg; 1988; 14(1):3-13. PubMed ID: 3136617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of scopolamine-induced amnesia and alterations in energy metabolism by the nootropic piracetam: implications regarding identification of brain structures involved in consolidation of memory traces.
    Piercey MF; Vogelsang GD; Franklin SR; Tang AH
    Brain Res; 1987 Oct; 424(1):1-9. PubMed ID: 3690290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memantine ameliorates scopolamine-induced amnesia in chicks trained on taste-avoidance learning.
    Barber TA; Haggarty MK
    Neurobiol Learn Mem; 2010 May; 93(4):540-5. PubMed ID: 20170739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scopolamine amnesia of passive avoidance: a deficit of information acquisition.
    Rush DK
    Behav Neural Biol; 1988 Nov; 50(3):255-74. PubMed ID: 3202811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sustained release formulation of thyrotropin-releasing hormone on learning impairments caused by scopolamine and AF64A in rodents.
    Miyamoto M; Hirai K; Takahashi H; Kato K; Nishiyama M; Okada H; Nagaoka A
    Eur J Pharmacol; 1993 Jul; 238(2-3):181-9. PubMed ID: 8405091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pregabalin on fear-based conditioned avoidance learning and spatial learning in a mouse model of scopolamine-induced amnesia.
    Sałat K; Podkowa A; Malikowska N; Trajer J
    Toxicol Mech Methods; 2017 Mar; 27(3):181-190. PubMed ID: 27996351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of ellagic acid against animal models of scopolamine- and diazepam-induced cognitive impairments.
    Mansouri MT; Farbood Y; Naghizadeh B; Shabani S; Mirshekar MA; Sarkaki A
    Pharm Biol; 2016 Oct; 54(10):1947-53. PubMed ID: 26828763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of DM-9384, a pyrrolidone derivative, on alcohol- and chlordiazepoxide-induced amnesia in mice.
    Nabeshima T; Tohyama K; Kameyama T
    Pharmacol Biochem Behav; 1990 Jun; 36(2):233-6. PubMed ID: 2113296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nootropic drugs in a scopolamine-induced amnesia model in mice.
    Verloes R; Scotto AM; Gobert J; Wülfert E
    Psychopharmacology (Berl); 1988; 95(2):226-30. PubMed ID: 3137602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.